RAD54L2 counters TOP2-DNA adducts to promote genome stability

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Topoisomerase 2 (TOP2) enzymes create transient DNA double-strand breaks (DSBs) during their catalytic cycle, forming TOP2 cleavage complexes (TOP2ccs).
• Anticancer drugs like etoposide stabilize TOP2ccs, leading to genotoxic protein-DNA cross-links that necessitate repair.
• Understanding TOP2cc resolution is crucial for cancer therapy and resistance mechanisms.

Purpose of the Study:

• To identify novel factors involved in the resolution of TOP2 cleavage complexes (TOP2ccs).
• To elucidate the mechanism by which RAD54 like 2 (RAD54L2) participates in TOP2cc resolution.
• To explore the therapeutic implications of RAD54L2 in cancer treatment.

Main Methods:

• Identification of RAD54L2 as a novel factor in TOP2cc resolution.
• Investigating the interaction of RAD54L2 with TOP2 and other proteins like ZATT/ZNF451.
• Assessing the role of RAD54L2's ATPase activity in the resolution process.
• Examining the impact of RAD54L2 on DSB exposure and DNA repair pathways.

Main Results:

• RAD54L2 was identified as a key factor promoting TOP2cc resolution.
• RAD54L2 functions through a novel mechanism involving ZATT/ZNF451, independent of TDP2.
• RAD54L2 recognizes sumoylated TOP2 and utilizes its ATPase activity to resolve TOP2ccs.
• RAD54L2 prevents the exposure of potentially genotoxic double-strand breaks.

Conclusions:

• RAD54L2 plays a critical role in resolving TOP2 cleavage complexes, preventing DNA double-strand breaks.
• The mechanism involves recognition of sumoylated TOP2 and ATP-dependent resolution.
• RAD54L2-mediated TOP2cc resolution may contribute to cancer therapy resistance.
• RAD54L2 represents a promising target for novel cancer drug discovery.